A section dedicated to medical achievements in south america. Specific areas will be later implemented if possible.
Recent Posts
Blog Stats
- 5,094 hits
Archives
- July 2018
- March 2018
- September 2016
- April 2016
- March 2016
- December 2015
- November 2015
- September 2015
- August 2015
- June 2015
- April 2015
- February 2015
- January 2015
- December 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- March 2014
- February 2014
- January 2014
- December 2013
- October 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- April 2012
- March 2012
- February 2012
- January 2012
- November 2011
- February 2011
- January 2011
Categories
Developing Medicine and CC
Developing Medicine by Francesco Corea is licensed under a Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Unported License.
1 comment
Comments feed for this article
March 12, 2013 at 12:13 am
anif2012
I recommend this article
Antibacterial drug resistance in Latin America: consequences for infectious disease control.
Rev Panam Salud Publica. 2011 Dec;30(6):519-28.
Casellas JM.
Abstract
Antibacterial drug resistance is a particularly significant issue in Latin America. This article explores antimicrobial resistance in three classes of clinically important bacteria: gram-positive bacteria, enterobacteria, and nonfermenting gram-negative bacilli. The gram-positive bacteria frequently responsible for infections in humans are for the most part cocci: staphylococci, streptococci (including pneumococci), and enterococci, in both community and hospital settings. This situation is no different in the Region of the Americas. Among the gram-positive bacteria, the causative agents of bacteremia are most commonly strains of coagulase-negative Staphylococcus, followed by enterococci. This report explores the resistance of these species to different antimicrobial drugs, resistance mechanisms in community and hospital strains, and new drugs for treating infections caused by these bacteria. In Latin America, antimicrobial resistance in Enterococcus strains is still a minor problem compared to the situation in the United States. The strains of the genus Streptococcus isolated from respiratory infections are still sensitive to penicillin. Furthermore, the resistance of enterobacteria is extremely important in the Region, particularly because of the broad dissemination of CTX-M extended-spectrum beta-lactamases (ESBL), some of which originated in Latin America. This article analyzes the resistance of Streptococcus pneumoniae, beta-hemolytic streptococci, and viridans group streptococci. Among the nonfermenting gram-negative bacilli, while Pseudomonas aeruginosa strains remain the leading cause of bacteremia, infections caused by strains of Acinetobacter spp. have proliferated extensively in some areas. With regard to antibiotics, several options are available for treating gram-positive bacterial infections. The same cannot be said for infections caused by enterobacteria and nonfermenting gram-negative bacilli, where options for the effective treatment of patients are still insufficient.
PDF